ZA712312B - 4,14-estradiene compounds - Google Patents

4,14-estradiene compounds

Info

Publication number
ZA712312B
ZA712312B ZA712312A ZA712312A ZA712312B ZA 712312 B ZA712312 B ZA 712312B ZA 712312 A ZA712312 A ZA 712312A ZA 712312 A ZA712312 A ZA 712312A ZA 712312 B ZA712312 B ZA 712312B
Authority
ZA
South Africa
Prior art keywords
estradiene
compounds
estradiene compounds
Prior art date
Application number
ZA712312A
Inventor
A Segaloff
R Gabbard
Original Assignee
Ochsner Med Found Alton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ochsner Med Found Alton filed Critical Ochsner Med Found Alton
Publication of ZA712312B publication Critical patent/ZA712312B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
ZA712312A 1970-04-28 1971-04-13 4,14-estradiene compounds ZA712312B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3272370A 1970-04-28 1970-04-28

Publications (1)

Publication Number Publication Date
ZA712312B true ZA712312B (en) 1972-01-26

Family

ID=21866473

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA712312A ZA712312B (en) 1970-04-28 1971-04-13 4,14-estradiene compounds

Country Status (2)

Country Link
GB (1) GB1341601A (en)
ZA (1) ZA712312B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW548277B (en) 1999-07-16 2003-08-21 Akzo Nobel Nv Orally active androgens
AU2001249661B2 (en) 2000-03-31 2005-02-17 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Methods of making the 4-n-butylcyclohexanoic and the undecanoic acid esters of (7 alpha, 11 beta)-dimethyl-17 beta-hydroxy-4-estren-3-one and their medical use
US20030069215A1 (en) 2001-03-30 2003-04-10 The Government Of The United States Of America, Methods of making and using 7a,11b-dimethyl-17b-hydroxy-4-estren-3-one 17b-trans-4-n-butylcyclohexane carboxylate and 7a,11b-dimethyl-17b-hydroxyestr-4-en-3-one 17-undecanoate
KR20030029640A (en) 2000-07-28 2003-04-14 악조 노벨 엔.브이. 16alpha-methyl or ethyl substituted estrogens
WO2002048169A1 (en) * 2000-12-15 2002-06-20 Akzo Nobel N.V. 14(15)-unsaturated 15- and/or 16- substituted androgens with mixed androgen-progestational profile
EP1379253B1 (en) * 2001-03-30 2006-03-29 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES Methods of making and pharmaceutical formulations comprising 7alpha,11beta-dimethyl-17beta-hydroxyestra-4, 14-dien-3-one and 17 esters thereof
UA89964C2 (en) 2004-09-08 2010-03-25 Н.В. Органон 15beta-substituted steroids having selective estrogenic activity

Also Published As

Publication number Publication date
GB1341601A (en) 1973-12-25

Similar Documents

Publication Publication Date Title
ZA71120B (en) 3,4 dihydro-1,2,3-oxathiazin-4-ones
IL37825A (en) 1-phenyl-8-chloro-2,3,4-5-tetrahydro-1h-1,5-benzodiazepin-2-one derivatives
IL35743A (en) 3-isopropyl-5-amino-1,2,4-thiadiazole compounds
HK78076A (en) 2,2-diaryl-4-(4-aryl-4-hydroxy-piperidino)-butyramides
IL38157A0 (en) N-substituted-2-carboxy-1-azacyclic compounds
ZA712312B (en) 4,14-estradiene compounds
CY922A (en) Benzobicycloalkane compounds
AU3731471A (en) Bis-triazole compounds
ZA712368B (en) 5,7-disubstituted-1,9-alkylene-1,4-benzodiazepin-2-ones
AU465145B2 (en) 2, 4-diamino-5-benzylpyrimidines
PH12851A (en) 1,2,3,4,5,6-hekahydro-1-oxo-2,6-methano-benzazocines
CA943126A (en) 4,14-estradiene compounds
ZA711840B (en) Pge3-type compounds
PH9363A (en) 5,6-trans-prostaglandins
IL37771A0 (en) 1,4-benzodioxanes
IL37724A (en) N-substituted-2,3-dihydro-2-oxo-5-phenyl-1h 1,4-benzodiazepine-1-carboxamides
CA837636A (en) 1,3-diazacyclo-2,4-butanediones
AU3151271A (en) Substituted 1, 3-indandiols
IE35197B1 (en) 1-dialkylphosphinylalkyl-2-oxo-5-alkylphenyl-1,2-dihydro-3h-benzo-(1,4)-diazepines
AU464322B2 (en) 4, 14-estradiene compounds
ZA714743B (en) Novel 1,2,5-benzotriazepines
IE34884B1 (en) 1,2,3-trithiane derivatives
PH9684A (en) 2,6-dinitroanilin derivatives
ZA713471B (en) 2,2-diaryl-4-(4'-aryl-4'-hydroxy-piperidino)butyramides
AU2775471A (en) 4, 14-estradiene compounds